Visual clue to new Parkinson's disease therapies

May 15, 2014
Immunohistochemistry for alpha-synuclein showing positive staining (brown) of an intraneural Lewy-body in the Substantia nigra in Parkinson's disease. Credit: Wikipedia

A biologist and a psychologist at the University of York have joined forces with a drug discovery group at Lundbeck in Denmark to develop a potential route to new therapies for the treatment of Parkinson's Disease (PD).

Dr Chris Elliott, of the Department of Biology, and Dr Alex Wade, of the Department of Psychology, have devised a technique that could both provide an of the disease and result in therapies to mitigate its symptoms.

In research reported in Human Molecular Genetics, they created a more sensitive test which detected neurological changes before degeneration of the nervous system became apparent.

In laboratory tests using , the researchers discovered that a human genetic mutation that causes Parkinson's amplified visual signals in young flies dramatically. This resulted in loss of vision in later life.

Working with researchers from the Danish pharmaceutical company, H.Lundbeck A/S, they tested a new drug that targets the Parkinson's mutation in flies. This drug prevented the abnormal changes in the flies' visual function.

It is the first time that the compound has been used in vivo and its effectiveness was analysed using the new, sensitive technique devised by Dr Wade. This was originally used for measuring vision in people with eye disease and epilepsy.

Dr Elliott, who is part-funded by Parkinson's UK, said: "If this kind of drug proves to be successful in clinical trials, it would have the potential to bring long-lasting relief from PD symptoms and fewer side effects than existing levadopa therapy."

Dr Wade added: "This technique forms a remarkable bridge between human clinical science and animal research. If it proves successful in the future, it could open the door to a new way of studying a whole range of neurological diseases."

Senior Vice President, Research at Lundbeck, Kim Andersen, said: "This new research may prove to be groundbreaking in the understanding and treatment of Parkinson's disease. Science does not currently have answers for what happens in the brain before and during the disease, but these discoveries may bring us closer to this understanding. This may also give us the opportunity to revolutionize the diagnosis and treatment of Parkinson's disease, for the benefit of patients and their families."

Explore further: Research uncovers a potential link between Parkinson's and visual problems

More information: The paper 'Abnormal visual gain control in a Parkinson's Disease model' is published in Human Molecular Genetics

Related Stories

Discovering Parkinson's cell mechanism

November 28, 2013

A new doctoral thesis from University of Stavanger suggests possible explanations of how a specific protein associated with Parkinson's disease (DJ-1) might be implicated in the onset of the disease.

Researchers investigating genetics of Parkinson's disease

March 11, 2014

(Medical Xpress)—Researchers at Emory University School of Medicine will study individuals with genetic mutations associated with Parkinson's disease (PD) as part of the Parkinson's Progression Markers Initiative (PPMI), ...

Treating depression in Parkinson's patients

April 18, 2014

A group of scientists from the University of Kentucky College of Medicine and the Sanders-Brown Center on Aging has found interesting new information in a study on depression and neuropsychological function in Parkinson's ...

Recommended for you

Major complication of Parkinson's therapy explained

September 10, 2015

Researchers have discovered why long-term use of L-DOPA (levodopa), the most effective treatment for Parkinson's disease, commonly leads to a movement problem called dyskinesia, a side effect that can be as debilitating as ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.